SEC Form 4 · accession 0001209191-17-017592
MAGELLAN HEALTH INC · MGLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barry M Smith
Officer — Chief Executive Officer · Director
Period of report
Feb 24, 2017
Accepted (ET)
Mar 3, 2017 · 4:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000019411
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Common Stock, $0.01 par valueF2 | Feb 24, 2017 | M | 12,671 | $0.00 | A | 36,235 | D | |
| Ordinary Common Stock, $0.01 par valueF4 | Feb 24, 2017 | F | 3,803 | $75.80 | D | 32,432 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2 | $0.00 | Feb 24, 2017 | M | 12,671 | D | Feb 24, 2017 | — | Common Stock | 12,671 | 2,534 | D |
Explanation of responses
- F1This transaction represents the vesting of 10,137 shares postponed from 2016 and 50% of the shares scheduled to vest in 2017 . Each Restricted Stock Unit represents a contingent right to receive one share of Magellan common stock.
- F2Not applicable.
- F3Represents the portion of shares withheld by the Company in order to pay taxes.
- F4Closing price on NASDAQ on February 1, 2017.